Tetra Bio-Pharma Inc. (TBPMF) Stock Analysis
DELISTED
What happened to Tetra Bio-Pharma Inc. (TBPMF) stock?
Tetra Bio-Pharma Inc. (TBPMF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $7.87M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Tetra Bio-Pharma Inc. (TBPMF). Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on cannabinoid-derived drug development for pain, inflammation, ophthalmology, and oncology. Their pipeline includes drugs targeting cancer pain, chemotherapy-induced nausea, acute respiratory distress syndrome, and other indications.
Last analyzed: Mar 18, 2026Tetra Bio-Pharma Inc. (TBPMF) Healthcare & Pipeline Overview
TBPMF OTC Market Information
TBPMF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy TBPMF shares?
No. TBPMF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for TBPMF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before TBPMF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Tetra Bio-Pharma Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.